Understanding and tracking the impact of long COVID in the United Kingdom

Ash Routen; Lauren O'Mahoney; Daniel Ayoubkhani; Amitava Banerjee; Chris Brightling; Melanie Calvert; Nishi Chaturvedi; Ian Diamond; Rosalind Eggo; Paul Elliott; Rachael A Evans; Shamil Haroon; Emily Herret; Margaret E O'Hara; Roz Shafran; Julie Stanborough; Terence Stephenson; Jonathan Sterne; Helen Ward; Kamlesh Khunti

doi:10.1038/s41591-021-01591-4

Understanding and tracking the impact of long COVID in the United Kingdom

Ash Routen, Lauren O'Mahoney, Daniel Ayoubkhani, Amitava Banerjee, Chris Brightling, Melanie Calvert, Nishi Chaturvedi, Ian Diamond, Rosalind Eggo, Paul Elliott, Rachael A Evans, Shamil Haroon, Emily Herret, Margaret E O'Hara, Roz Shafran, Julie Stanborough, Terence Stephenson, Jonathan Sterne, Helen Ward, Kamlesh Khunti^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate (Academic Journal) › peer-review

18 Citations (Scopus)

Abstract

[No abstract]

Original language	English
Pages (from-to)	11-15
Number of pages	5
Journal	Nature Medicine
Volume	28
Issue number	1
Early online date	22 Nov 2021
DOIs	https://doi.org/10.1038/s41591-021-01591-4
Publication status	Published - 1 Jan 2022

Bibliographical note

Funding Information:
M.C. is Director of the Birmingham Health Partners Centre for Regulatory Science and Innovation, Director of the Centre for Patient Reported Outcomes Research and is a NIHR Senior Investigator. M.C. receives funding from the NIHR Birmingham Biomedical Research Centre, the NIHR Surgical Reconstruction and Microbiology Research Centre and NIHR ARC West Midlands at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Health Data Research UK, Innovate UK (part of UKRI), Macmillan Cancer Support, UCB and GSK Pharma. M.C. has received personal fees from Astellas, Aparito Ltd, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute (PCORI) outside of the submitted work. N.C. has received funding from AstraZeneca to serve on Data Safety and Monitoring Committees for clinical trials. K.K. is a director of the University of Leicester Centre for Ethnic Health Research, trustee of the South Asian Health Foundation, and chair of the Ethnicity Subgroup of the Scientific Advisory Group for Emergencies (SAGE). P.E. is director of the MRC Centre for Environment and Health and the NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards. P.E. is a foundation professor of the UK Dementia Research Institute at Imperial College, an Associate Director of Health Data Research UK (London), and leads the Informatics and Biobanking theme at the NIHR Imperial Biomedical Research Centre.

Access to Document

10.1038/s41591-021-01591-4

Handle.net

Persistent link

Cite this

Routen, A., O'Mahoney, L., Ayoubkhani, D., Banerjee, A., Brightling, C., Calvert, M., Chaturvedi, N., Diamond, I., Eggo, R., Elliott, P., Evans, R. A., Haroon, S., Herret, E., O'Hara, M. E., Shafran, R., Stanborough, J., Stephenson, T., Sterne, J., Ward, H., & Khunti, K. (2022). Understanding and tracking the impact of long COVID in the United Kingdom. Nature Medicine, 28(1), 11-15. https://doi.org/10.1038/s41591-021-01591-4

@article{40c0cf2887f24b638cac9ce783c4445b,

title = "Understanding and tracking the impact of long COVID in the United Kingdom",

abstract = "[No abstract]",

author = "Ash Routen and Lauren O'Mahoney and Daniel Ayoubkhani and Amitava Banerjee and Chris Brightling and Melanie Calvert and Nishi Chaturvedi and Ian Diamond and Rosalind Eggo and Paul Elliott and Evans, {Rachael A} and Shamil Haroon and Emily Herret and O'Hara, {Margaret E} and Roz Shafran and Julie Stanborough and Terence Stephenson and Jonathan Sterne and Helen Ward and Kamlesh Khunti",

note = "Funding Information: M.C. is Director of the Birmingham Health Partners Centre for Regulatory Science and Innovation, Director of the Centre for Patient Reported Outcomes Research and is a NIHR Senior Investigator. M.C. receives funding from the NIHR Birmingham Biomedical Research Centre, the NIHR Surgical Reconstruction and Microbiology Research Centre and NIHR ARC West Midlands at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Health Data Research UK, Innovate UK (part of UKRI), Macmillan Cancer Support, UCB and GSK Pharma. M.C. has received personal fees from Astellas, Aparito Ltd, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute (PCORI) outside of the submitted work. N.C. has received funding from AstraZeneca to serve on Data Safety and Monitoring Committees for clinical trials. K.K. is a director of the University of Leicester Centre for Ethnic Health Research, trustee of the South Asian Health Foundation, and chair of the Ethnicity Subgroup of the Scientific Advisory Group for Emergencies (SAGE). P.E. is director of the MRC Centre for Environment and Health and the NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards. P.E. is a foundation professor of the UK Dementia Research Institute at Imperial College, an Associate Director of Health Data Research UK (London), and leads the Informatics and Biobanking theme at the NIHR Imperial Biomedical Research Centre.",

year = "2022",

month = jan,

day = "1",

doi = "10.1038/s41591-021-01591-4",

language = "English",

volume = "28",

pages = "11--15",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Springer Nature",

number = "1",

}

Routen, A, O'Mahoney, L, Ayoubkhani, D, Banerjee, A, Brightling, C, Calvert, M, Chaturvedi, N, Diamond, I, Eggo, R, Elliott, P, Evans, RA, Haroon, S, Herret, E, O'Hara, ME, Shafran, R, Stanborough, J, Stephenson, T, Sterne, J, Ward, H & Khunti, K 2022, 'Understanding and tracking the impact of long COVID in the United Kingdom', Nature Medicine, vol. 28, no. 1, pp. 11-15. https://doi.org/10.1038/s41591-021-01591-4

TY - JOUR

T1 - Understanding and tracking the impact of long COVID in the United Kingdom

AU - Routen, Ash

AU - O'Mahoney, Lauren

AU - Ayoubkhani, Daniel

AU - Banerjee, Amitava

AU - Brightling, Chris

AU - Calvert, Melanie

AU - Chaturvedi, Nishi

AU - Diamond, Ian

AU - Eggo, Rosalind

AU - Elliott, Paul

AU - Evans, Rachael A

AU - Haroon, Shamil

AU - Herret, Emily

AU - O'Hara, Margaret E

AU - Shafran, Roz

AU - Stanborough, Julie

AU - Stephenson, Terence

AU - Sterne, Jonathan

AU - Ward, Helen

AU - Khunti, Kamlesh

N1 - Funding Information: M.C. is Director of the Birmingham Health Partners Centre for Regulatory Science and Innovation, Director of the Centre for Patient Reported Outcomes Research and is a NIHR Senior Investigator. M.C. receives funding from the NIHR Birmingham Biomedical Research Centre, the NIHR Surgical Reconstruction and Microbiology Research Centre and NIHR ARC West Midlands at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Health Data Research UK, Innovate UK (part of UKRI), Macmillan Cancer Support, UCB and GSK Pharma. M.C. has received personal fees from Astellas, Aparito Ltd, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute (PCORI) outside of the submitted work. N.C. has received funding from AstraZeneca to serve on Data Safety and Monitoring Committees for clinical trials. K.K. is a director of the University of Leicester Centre for Ethnic Health Research, trustee of the South Asian Health Foundation, and chair of the Ethnicity Subgroup of the Scientific Advisory Group for Emergencies (SAGE). P.E. is director of the MRC Centre for Environment and Health and the NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards. P.E. is a foundation professor of the UK Dementia Research Institute at Imperial College, an Associate Director of Health Data Research UK (London), and leads the Informatics and Biobanking theme at the NIHR Imperial Biomedical Research Centre.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - [No abstract]

AB - [No abstract]

U2 - 10.1038/s41591-021-01591-4

DO - 10.1038/s41591-021-01591-4

M3 - Comment/debate (Academic Journal)

C2 - 34811549

SN - 1078-8956

VL - 28

SP - 11

EP - 15

JO - Nature Medicine

JF - Nature Medicine

IS - 1

ER -

Understanding and tracking the impact of long COVID in the United Kingdom

Abstract

Bibliographical note

Access to Document

Handle.net

Fingerprint

Cite this